← Back to Resources
AnnouncementPatient accessAI in healthcarePartnership

Infinx Invests in Voxology AI to Bring Conversational AI Agents to Patient Scheduling

Strategic investment integrates voice-first automation into Infinx's contact center solutions, expanding capabilities from back-office revenue cycle management to patient-facing front-office workflows.

Voxology AI1 min read
Infinx Invests in Voxology AI to Bring Conversational AI Agents to Patient SchedulingRead announcement

Infinx, an AI-powered solutions provider for patient access and revenue cycle management, announced a strategic investment in Voxology AI, a healthcare technology company developing conversational AI agents for front-office operations.

The partnership integrates voice-first automation into Infinx's contact center solutions, expanding capabilities from back-office revenue cycle management to patient-facing front-office workflows. Providers can deploy AI scheduling agents through a unified platform.

What it means for providers

AI agents handle appointment scheduling, changes, and triage in English, Spanish, and additional languages. Three deployment models are offered: standalone SaaS, tech-enabled contact center service, or hybrid approach.

Reported outcomes include:

  • 40%--60% reduction in front-office administrative calls
  • 5%--7% increase in new patient appointments
  • 95%+ reduction in after-hours answering service volumes

What leaders are saying

"With Voxology's AI agents embedded into our patient access workflows, providers can offer 24/7 scheduling support without adding headcount."

--- Jaideep Tandon, CEO, Infinx

"Phone calls are still the #1 way patients schedule appointments. That moment is where both patient experience and revenue truly begin."

--- Aakarsh Sethi, Founder & CEO, Voxology AI

"Scaling that into a production workload that's accurate, resilient, and backed by real operations, that's where most fail."

--- Navaneeth Nair, Chief Product Officer, Infinx


Originally published on Newswire on October 10, 2025.